-
13/12/2019 ore 16:53Friulchem approves the transaction with related party
-
28/11/2019 ore 17:55Friulchem approves the framework resolution concerning the contract for the supply of raw materials with Evultis
-
15/10/2019 ore 07:15Friulchem obtains authorization for the marketing in South Africa of an antibiotic for human use with a wide spectrum of action for serious infections
Friulchem S.p.A. (AIM: FCM), announces that it has obtained, after a "registration process" of over 5 years, the authorization for the marketing in South Africa of a broad-spectrum antibiotic for human use (injectable betalactam belonging to the class of carbapenems for the treatment of serious infections) and to have entered into an agreement with a leading multinational pharmaceutical company - world leader in the distribution of generic drugs - for exclusive distribution in South Africa.
-
27/09/2019 ore 18:47Friulchem continues its internationalization process with the establishment of Friulchem USA Inc.
Friulchem S.p.A. (AIM: FCM) communicates the constitution of the Friulchem USA Inc. company. The newly company will be active in the marketing and distribution of feed supplement or non-pharmaceutical products for the North American veterinary sector.
-
27/09/2019 ore 09:30CEO at the 2019 semi-annual report
Disma Giovanni Mazzola, CEO of Friulchem S.p.A. (AIM: FCM) commented on the 2019 half-year figures
-
26/09/2019 ore 17:55Friulchem: the half-year report as of June 30, 2019 approved
-
29/07/2019 ore 17:58SIGNIFICANT SHAREHOLDERS (Available only in Italian)
-
25/07/2019 ore 18:01CORPORATE EVENTS CALENDAR 2019 (Available only in Italian)
-
23/07/2019 ore 18:37NOTIFIED TO CONSOB THE KID - "KEY INFORMATION DOCUMENT" CONCERNING THE "WARRANT FRIULCHEM 2019-2022"
-
23/07/2019 ore 16:25FRIULCHEM S.p.A. ADMITTED TO TRADING ON THE AIM ITALIA MARKET